Всего найдено: 2

Endovascular treatment for iliac arteries atherosclerotic lesions

DOI: https://doi.org/10.25512/DIR.2010.04.2.05

For quoting:
Zatevakhin I.I., Shipovskiy V.N., Magomedov Sh.G., Dzhurakulov Sh.R. "Endovascular treatment for iliac arteries atherosclerotic lesions". Journal Diagnostic & interventional radiology. 2010; 4(2); 29-37.

authors:

Zatevakhin I.I.

Shipovskiy V.N.

Magomedov Sh.G.

Dzhurakulov Sh.R.

keywords:

endovascular interventions

terminal aorta iliac arteries

chronic lower limbs ischemia

Abstract:

Purpose. To assess early and late results of iliac arteries balloon angioplasty and stenting in patients with chronic lower limb ischemia.

Material and methods. We analyzed the results of terminal aortic and iliac lesions endovascular treatment in 222 patients. All the patients presented symptoms of lower-limb chronic ischemia: 2nd «b» grade - 51,2%; 3rd grade - 27,1%; 4th grade - 21,7%. Two hundred and fifty eight procedure were performed, including 98 (38%) balloon angioplasty and 160 (62%) stenting. The lesions were Type A -26%, Type B - 45%, Type C - 23%, and Type D - 51% according to TASC II classification.

Results. Immediate angiographic success rate was 99,4%, complication rate -1,3% (4 of 314). Cumulative primary patency after balloon angioplasty in terms of 1, 3 and 5 years were correspondingly 97,9%, 82,0% and 64,2%. After stenting it was as high as 98,1%, 85,2% and 71,8%. Secondary patency after balloon angioplasty in terms of 1, 3 and 5 years was correspondingly 99,0%, 89,4% и 75,6%. For stenting it was 99,4%, 93,0% and 85,6% (Kaplan - Meier). Long-term clinical success rates in 1 year, 3 and 5 years were correspondingly 97,9%, 98,7% and 88,8% for angioplasty and 92,6%, 63,7% and 72,6% for stenting. Five-year limb preservation rate was 92,4% for angioplasty and 98,6% for stenting.

Conclusions. Endovascular interventions are proved to be safe and efficient for iliac arteries atherosclerotic lesions, and to have good long-term results.

References

1. Кошкин В.М. Амбулаторное лечение атеросклеротических поражений сосудов нижних конечностей. Ангиология и сосудистая хирургия. 1999; 1: 106 -113.

2. Покровский А.В. и др. Российский консенсус. Рекомендуемые стандарты для оценки результатов лечения пациентов с хронической ишемией нижних конечностей. М.2001; 16.

3. Kannel W. et аl. Intermittent Claudication:incidence in the Framingham-Study. Circulation. 1970; 41: 875-883.

4. Живарев Г.В., Коротков Н.И., Александров А.Л. и др. Исходы аортобедренного шунтирования при синдроме Лериша. III всероссийский съезд сердечно-сосудистых хирургов. М. 1996; 253.

5. Казанчян П.О., Попов В.А., Дебелый Ю.В. и др. Аорто-подвздошно-бедренные реконструкции методом эверсионной эндартерэктомии. Разумный возврат к прошлому. Ангиология и сосудистая хирургия. 1999; 5: 71-80.

6. Гуч А.А., Верещагин С.В., Кондратюк В.А. Определение показаний к первичному рентгеноэндоваскулярному протезированию артерий подвздошно-бедренного сегмента. Эхография. 2000; 1 (2): 155-158.

7. Bosch J.L., Hunink M.G.M. Metaanalysis of the results of percutaneus transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology. 1997; 204: 87-96.

8. TASC II. Transatlantic Intersociety Consensus (TASC) document on management of peripheral arterial disease. Eur. J. Vase. Endovasc. Surg. 2007; 1: 63-65.

9. Saket R.R. et аl. Novel intravascular ultrasound-guided method to create transintimal arterial communications: initial experience in peripheral occlusive disease and aortic dissection. J. Endovasc. Ther. 2004; 11 (3): 274-280.

10. Becker G.J. et аl. Noncoronary angioplasty. Radiology. 1989; 170 (3): 921-940.

11. Затевахин И.И., Дроздов С.А., Хабазов Р.И. Допплеросфигмоманометрия в диагностике поражений глубокой артерии бедра. Клиническая хирургия. 1985; 7: 24-2

Long-term results of stenting and balloon angioplasty in patients with occlusive-stenotic lesions of femoral-popliteal segment

DOI: https://doi.org/10.25512/DIR.2014.08.4.07

For quoting:
Zatevakhin I.I., Shipovskiy V.N., Dzhurakulov Sh.R., Tursunov S.B., Khalimov A.D. "Long-term results of stenting and balloon angioplasty in patients with occlusive-stenotic lesions of femoral-popliteal segment". Journal Diagnostic & interventional radiology. 2014; 8(4); 67-71.

authors:

Zatevakhin I.I.

Shipovskiy V.N.

Dzhurakulov Sh.R.

Tursunov S.B.

Khalimov A.D.

keywords:

femoral-popliteal segment

stenting

balloon angioplasty

Abstract:

Article describes results of single-balloon angioplasty and stenting in patients with occlusive-stenotic lesions of femoral-popliteal segment for the period of 30 months. It was performed 209 endovascular interventions, single-balloon angioplasty in 95 patients; stenting - 114 patients. Long-term results of primary patency: 43,1% in group of single-balloon angioplasty 57,1% - in group with stenting.

References

1. Рекомендуемые стандарты для оценки результатов лечения пациентов с хронической ишемией нижних конечностей. Российский консенсус. Казань 2001. Rekomenduemye standarty dlja ocenki rezul'tatov lechenija pacientov s hronicheskoj ishemiej nizhnih konechnostej. Rossijskij consensus [Recommended standarts for estimation of treatment results in patients with chronic ischemia of lower limbs. Russian Consensus]. Kazan' 2001 [ In Russ].

2. Klinicheskaja angiologija [Clinical angiology]. Pod red. akad. Pokrovskogo A.V. M., 2004; 1: 69 [In Russ].

3. Nacional'nye rekomendacii po vedeniju bol'nyh s zabolevanijami arterij nizhnih konechnostej [National recommendation for treatment of patients with diseases of lower limbs’ arteries.]. M., 2013[In Russ].

4. Hunink M.M., Donaldson M.C., Meyerovitz M.F., et al. Risks and benefits of femoropopliteal percutaneous balloon angioplasty. J. Vasc. Surg. 1993; 17: 183-194.

5. Becquemin J-P, Cavillon A., Haiduc F. Surgical transluminal femoropopliteal angioplasty: multivariate analysis outcome. J. Vasc .Surg .1994; 19: 495-502.

6. Murray R.R., Hewes R.C., White R.I., et al. Long-segment femoropopliteal stenoses: is angioplasty a boom or a bust? Radiology .1987; 162: 473-476.

7. Johnston K.W. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology. 1992; 183:767-71.

8. Krankenberg H., Schluter M., Steinkamp H.J., et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to

10 cm in length: the Femoral Artery Stenting Trial (FAST). Circulation. 2007; 116:285-92.

9. Dake M., Ansel G., Jaff M., et al. Zilver PTX: a prospective, randomized trial of the polymer-free paclitax-eleluting stent compared to balloon angioplasty with provisional bare metal stenting in patients with superficial femoral artery disease (abstr). Paper presented at: Twenty-Second Annual Transcatheter Cardiovascular Therapeutics Symposium;September 21-25; Washington, DC. J. Am. Coll. Cardiol. 2010;56:xiii.

10. Bergeron P., Pinot J.J., Poyen V., et al. Long-term results with the Palmaz stent in the superficial femoral artery. J. Endovasc. Surg. 1995; 2: 161-167.

11. Henry M., Amor M., Henry I., et al. Placement of Palmaz stent in femoropopliteal arteries: a six year experience. Factors influencing restenosis and longterm results. In: Abstract Book 6° International course on peripheral vascular intervention. Oct 1995, Nancy, France.

12. Dake M., Ansel G., Jaff M., et al. Zilver PTX: a prospective, randomized trial of the polymer-free paclitax-eleluting stent compared to balloon angioplasty with provisional bare metal stenting in patients with superficial femoral artery disease (abstr). Paper presented at: Twenty-Second Annual Transcatheter Cardiovascular Therapeutics Symposium;September 21-25; Washington, DC. J. Am. Coll. Cardiol. 2010;56.